Table 1 Clinical characteristics of patients with BM (n = 116)
From: Analysis of prognostic factors in patients with brain metastases affecting survival
Variables | Options | Number (%) |
|---|---|---|
Age | 18–30 years | 04 (3.4) |
31–40 years | 07 (6.0) | |
41–50 years | 38 (32.8) | |
51–60 years | 35 (30.2) | |
61–70 years | 25 (21.6) | |
More than 70 years | 07 (6.0) | |
Gender | Male | 71 (61.2) |
Female | 45 (38.8) | |
Primary site of cancer | Lung | 80 (68.9) |
Breast | 23 (19.8) | |
Gynecological | 03 (2.58) | |
Soft tissue sarcoma | 02 (1.72) | |
Gastrointestinal | 02 (1.72) | |
Genitourinary | 03 (2.58) | |
Others | 03 (2.58) | |
Histopathology | SCLC | 20 (17.2) |
Adenocarcinoma | 41 (35.3) | |
Squamous | 21 (18.2) | |
Others | 34 (29.3) | |
Extracranial metastasis | Liver | 09 (7.8) |
Bone | 3 (26.7) | |
Adrenal | 05 (4.3) | |
Clinical presentation of brain metastasis | Headache | 64 (55.3) |
Seizures | 15 (12.9) | |
Weakness | 30 (25.8) | |
Asymptomatic | 07 (6.0) | |
RPA | I | 51 (43.9) |
II | 15 (13.0) | |
III | 50 (43.1) | |
Number of BM | Single | 30 (25.8) |
Multiple | 86 (74.2) | |
Location of BM | Cerebrum | 50 (43.1) |
Cerebellum | 06 (5.2) | |
Multiple | 60 (51.7) | |
Time of occurrence of BM | Synchronous | 43 (37.1) |
Metachronous | 73 (62.9) |